Dr. Hunter just performed the first Invisible Spinal Cord Stimulator (SCS) Trial in the state…
Better Living Through Chemistry
Infusion therapy is becoming increasingly more popular for treating patients with neuropathy, chronic pain and depression. The reasons are simple…the ease with which it can be performed and the results are astonishing.
Depending on the agent used, the infusion session can completed in as little time as 30 minutes. There are a variety of different medications your doctor can use to perform the infusion, including Lidocaine, Ketamine, IVIG, Magnesium and the list goes on. Once your doctor places the IV line in your arm or hand, the hard work is over. The only thing left to do is making yourself comfortable and let the medication work its magic. In many cases the effect is immediate.
Infusion therapy is covered by most insurances and considered an appropriate treatment for a variety of types of pain. Certain types of infusion (IVIG for example) may require a prior authorization and certain lab work to be completed beforehand.
What types of conditions can be treated with IV infusion therapy?
- Neuropathic Pain
- Diabetic Peripheral Polyneuropathy
- Neuropathy
- Headaches & Facial Pain
- Post Stroke Pain
- Peripheral Nerve Injury
- Complex Regional Pain Syndrome & Reflex Sympathetic Dystrophy
- Post-Herpetic Neuralgia
- Fibromyalgia
- Post-Surgical Pain
- Depression
Are there any complications or side effects? Each medication has its own unique mechanism of action which means each one has its own distinctive set of possible side effects. For example, a patient receiving a Ketamine infusion might experience some mild sedation where as someone getting Lidocaine might have metallic taste in their mouth. People generally tolerate infusions quite well.
Latest posts by Corey Hunter, M.D. (see all)
- Hydrodissection – Science or Science Fiction - March 23, 2021
- Facebook Live 2 – Full Video - April 2, 2020
- (Full Presentation) Top 5 Things Pain Patients Need To Know During The Coronavirus Pandemic - March 30, 2020